Oncternal Therapeutics, Inc.

NASDAQ:ONCT

0.5266 (USD) • At close December 2, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999
Omzet 0.7851.494.3153.3752.4252.5211.674-2.511000014.73960.61314.7313.5287.1267.5053.7821.86700000
Kosten van de omzet 29.7530.1790.1691210.1590.0460.0472.5110.0430001.0550.7681.290.6490.6210.7731.573000000
Brutowinst -28.9681.3114.146-8.625-7.7342.4751.627-5.022-0.04300013.68459.84513.4412.8796.5056.7322.2091.86700000
Brutowinstmarge -36.9020.880.961-2.556-3.1890.9820.972200000.9280.9870.9120.9520.9130.8970.584100000
Onderzoek- en ontwikkelingskosten 29.75332.9824.08612.54410.15929.66921.46717.22813.60720.8732.31838.88731.93828.49532.34444.25938.50833.89730.92317.9510.4689.2855.9212.6790.518
Algemene en administratieve kosten 12.54613.45711.5958.3737.2869.399.1888.7058.2349.47811.28110.845017.41927.74923.10513.50111.3529.8457.2113.5120000
Verkoop- en marketingkosten 0.2000000000000000000000000
Verkoop-, algemene en administratieve kosten 12.74613.45711.5958.3737.2869.399.1888.7058.2349.47811.28110.84515.43817.41927.74923.10513.50111.3529.8457.2113.5122.4052.2251.2030.256
Overige kosten -29.753-1.49-4.315-3.375-2.4250.6410.2160.0460.057-0.2591.488-0.01915.43800013.50111.3529.8457.2110.3570000
Bedrijfskosten 12.74644.94731.36617.54215.0239.05930.65525.93321.84130.34843.59949.73247.37645.91460.09367.36452.00945.24940.76825.16114.33712.0228.1463.9620.819
Bedrijfsresultaat -41.714-44.947-31.366-17.542-33.108-39.059-30.655-25.933-21.841-30.348-43.599-49.732-33.69213.931-46.653-54.485-45.504-38.517-38.559-23.294-14.337-12.022-8.146-3.962-0.819
Bedrijfsresultaat ratio -53.139-30.166-7.269-5.198-13.653-15.493-18.31210.3280000-2.2860.23-3.167-4.028-6.386-5.132-10.195-12.47700000
Totaal overige inkomsten en kosten netto 2.2350.7770.0330.317-1.081.0070.2168.2093.138-9.0631.488-0.0190.3981.3630.1592.7055.1453.0071.7217.616-81.1370000
Inkomen voor belasting -39.479-44.17-31.333-17.225-34.188-38.418-30.439-17.724-18.703-39.411-42.111-49.751-33.29415.294-46.494-51.78-40.359-35.51-36.839-5.678-95.4740000
Inkomen voor belasting ratio -50.292-29.644-7.261-5.104-14.098-15.239-18.1837.0590000-2.2590.252-3.156-3.828-5.664-4.732-9.741-3.04100000
Belastingkosten 0-0.777-0.033-0.016-18.2760.641-0.047-8.191-3.1248.702-0.384-8.821-1.438-2.936-0.238-1.5624.9-72.0260.29917.25-0.143-0.1568.063-0.15-0.069
Nettowinst -39.479-43.393-31.3-17.209-15.912-38.418-30.439-17.724-18.703-39.411-42.111-27.075-33.29415.294-46.256-51.78-40.359-35.51-36.839-22.348-14.194-11.866-8.063-3.812-0.75
Nettowinstmarge -50.292-29.123-7.254-5.099-6.562-15.239-18.1837.0590000-2.2590.252-3.14-3.828-5.664-4.732-9.741-11.9700000
WPA (Winst Per Aandeel) -13.43-16.5-12.69-16.95-30.81-11.52-12.22-8.52-9.33-33.72-46.75-30.17-40.6327.3-88.92-99.85-80.86-79.8-99.25-68.04-128.45-107.39-72.85-34.5-6.79
Verwaterde WPA -13.43-16.5-12.69-16.95-30.81-11.52-12.22-8.52-8.86-33.72-46.75-30.17-40.6327.3-88.92-99.85-80.86-79.8-99.25-65.01-128.45-107.39-72.85-34.5-6.79
EBITDA 2.235-44.947-31.366-17.542-33.1081.008-30.392-17.696-18.66-39.309-41.727-49.001-34.0916.867-44.709-52.923-45.504-34.37-38.559-23.2940-11.69-8.146-3.882-0.774
EBITDA ratio 2.847-30.166-7.269-5.198-6.116-15.475-18.31213.5790000-2.3130.207-3.046-4.028-6.386-5.132-10.195-12.47700000